Clinical Trial Update: A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating GSK5926371 in participants with B-cell driven autoimmune rheumatic diseases, including systemic lupus erythematosus, is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• GSK5926371

Snippet

Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: RECRUITING